US AIDS Group Hails Brazil for Breaking Merck’s AIDS Drug Patent

Brazil produces some of its own AIDS drugs AIDS Healthcare Foundation (AHF), the US' largest provider of HIV/AIDS healthcare, education and prevention hailed the news that the President of Brazil, Luiz Inácio Lula da Silva, signed today a compulsory license for Merck's HIV/AIDS drug Efavirenz, freeing the country to buy a generic formula of the medication or produce it in its all state laboratories.

AHF also operates free AIDS treatment clinics in the US, Africa, Latin America/Caribbean and Asia. For them, Lula's move is seen as a victory for global AIDS activism and AIDS patients worldwide.

President Lula de Silva's decision comes after reports of a breakdown in negotiations between Brazil and the New Jersey based drug giant Merck. According to the country's health ministry, Brazil had asked Merck to cut the price of Efavirenz to 65 cents a pill from $1.57 and Merck had refused.

Brazil's decision to issue a compulsory license for the drug, which will allow the country to manufacture the drug or to buy generic versions, comes on the heels of Thailand's recent move to issue a compulsory license for Abbott's AIDS drug, Kaletra and in the lead-up to an AIDS Healthcare Foundation-hosted discussion regarding AIDS drug-pricing for Mexico, scheduled for June 4th in Mexico City.

"In announcing its intention to issue a compulsory license for Merck's AIDS drug Efavirenz, Brazil is once again leading the way to affordable AIDS drug access for every nation," added Michael Weinstein, President of AIDS Healthcare Foundation.

"We salute the courage of countries such as Brazil, Thailand and Mexico who are fighting to ensure drug access for AIDS patients the world over. Today is a victory for AIDS activists and patients everywhere, and proof that drug companies will go down in defeat every time they place themselves in the way of justice for AIDS patients."

Flexibilities under the World Trade Organization's (WTO) Trade-related Aspects of Intellectual Property Rights (TRIPS) Agreement allow governments to issue compulsory licenses (including royalty payment to the patent owner) if the country deems it necessary and appropriate to protect the health of its citizens.

Brazil has been widely praised by global AIDS treatment activists for its government AIDS program, which provides free medication for anyone who needs it.

In the Latin American region, AIDS Healthcare Foundation operates free HIV/AIDS treatment clinics in Guatemala (Quetzaltenango) and in Mexico (Tijuana and Puerto Vallarta).

Tags:

You May Also Like

Brazil Corruption: 30% of Senators Have Problems with Justice

According to a report just published by daily newspaper Folha de S. Paulo, a ...

House of Horrors

In Minas Gerais, police stations torture methods used in the 1960s are still in ...

Tested in Brazil New Vaccine Works on Cervical Cancer

Gardasil, the investigational vaccine against Human Papillomavirus (HPV) from Merck & Co., Inc., significantly ...

The Brazil Risk and Brazil at Risk

In Brazil, crime has become a political party that runs not for elections, but ...

For Brazil’s Beef Industry the Worst of Crisis Is Over

Brazilian exports of raw beef are starting to show signs of recovery. Figures supplied ...

Jorge Ben Jor back in the USA

“I am an urban suburban poet and my beat stays the same,” says Jorge ...

Brazil’s Sports Minister Likely to Be 5th Rousseff’s Cabinet Member to Fall for Corruption

Veja, the weekly magazine with the largest circulation in Brazil (about 1.1 million copies) ...

Arabs and Israelis March in Brazil Against the War

At least 4,000 people, according to the Military Police, marched this Sunday, August 6, ...

Multinational’s GMS Experimental Field Invaded by Brazilian Activists

Members of the world network of rural workers "Via Campesina" invaded this Tuesday, March ...

Brazilian Trade Relations with Arabs Keep on Growing

Trade relations between Brazilians and Arabs are entering a new and important phase: investment. ...